{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:59:32Z","timestamp":1780646372719,"version":"3.54.1"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["ECR\/2018\/000723"],"award-info":[{"award-number":["ECR\/2018\/000723"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jconrel.2023.08.043","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T12:22:15Z","timestamp":1693570935000},"page":"297-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Nanocarrier based active targeting strategies against erythrocytic stage of malaria"],"prefix":"10.1016","volume":"362","author":[{"given":"Atharva R.","family":"Bhide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanashree H.","family":"Surve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil B.","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.08.043_bb0010","series-title":"High burden to high impact A targeted malaria response","first-page":"1","author":"WHO","year":"2018"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0015","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1295381","article-title":"Old and recent advances in life cycle, pathogenesis, diagnosis, prevention, and treatment of malaria including perspectives in Ethiopia","volume":"2020","author":"Nureye","year":"2020","journal-title":"Sci. World J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.00079-12","article-title":"Human infections and detection of plasmodium knowlesi","volume":"26","author":"Singh","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0025","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1016\/S2214-109X(17)30333-9","article-title":"Outbreak of human malaria caused by plasmodium simium in the Atlantic Forest in Rio de Janeiro: a molecular epidemiological investigation","volume":"5","author":"Brasil","year":"2017","journal-title":"Lancet Gob. Heal."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/bmb\/ldh031","article-title":"Current issues in the treatment of uncomplicated malaria in Africa","volume":"71","author":"Bell","year":"2004","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR network","volume":"93","author":"Cui","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2017.04.042","article-title":"Recent advances in use of silver nanoparticles as antimalarial agents","author":"Rai","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejps.2018.10.017","article-title":"Combination drug therapy via nanocarriers against infectious diseases","volume":"127","author":"Walvekar","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0050","article-title":"A multilamellar nanoliposome stabilized by interlayer hydrogen bonds increases antimalarial drug efficacy, nanomedicine nanotechnology","volume":"22","author":"Fotoran","year":"2019","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0055","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.2147\/IJN.S227914","article-title":"Effects of surface characteristics of polymeric nanocapsules on the pharmacokinetics and Efficacy of antimalarial Quinine","volume":"14","author":"Michels","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120820","article-title":"Fabrication and evaluation of artemether loaded polymeric nanorods obtained by mechanical stretching of nanospheres","volume":"605","author":"Bhide","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0065","series-title":"Evaluation of Pharmacokinetics, Biodistribution, and Antimalarial Efficacy of Artemether-Loaded Polymeric Nanorods","author":"Bhide","year":"2022"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0070","doi-asserted-by":"crossref","DOI":"10.1080\/10826076.2020.1777564","article-title":"A sensitive RP-HPLC method for estimation of artemether from polymeric nanoparticles after pre-column acid treatment using UV-visible detector","author":"Bhide","year":"2020","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/acsinfecdis.2c00336","article-title":"Single-chain polymer nanoparticles targeting the Ookinete stage of malaria parasites","volume":"9","author":"Hamelmann","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0080","first-page":"3865","article-title":"Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles","volume":"9","author":"Ogutu","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0085","article-title":"Advances in curcumin loaded Nanopreparations: improving bioavailability and overcoming inherent drawbacks","volume":"27","author":"Yanan","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2016.09.008","article-title":"Nanostructured lipid carriers of artemether\u2013lumefantrine combination for intravenous therapy of cerebral malaria","author":"Prabhu","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0095","article-title":"Artemether\u2013lumefantrine nanostructured lipid carriers for oral malaria therapy: enhanced efficacy at reduced dose and dosing frequency","author":"Prabhu","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2015.05.284","article-title":"Immunoliposome-mediated drug delivery to plasmodium-infected and non- infected red blood cells as a dual therapeutic\/prophylactic antimalarial strategy","volume":"210","author":"Moles","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0105","first-page":"2809","article-title":"Serum albumin nanoparticles for effective control of malaria-infected erythrocytes","volume":"11","author":"Aditi","year":"2016","journal-title":"Nanomedicine(Lond.)"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0110","first-page":"1","article-title":"Polyamidoamine nanoparticles for the oral administration of antimalarial drugs","volume":"10","author":"Coma-cros","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2015.02.011","article-title":"Preferential targeting of human erythrocytes infected with the malaria parasite plasmodium falciparum via hexose transporter surface proteins","volume":"483","author":"Heikham","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0120","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.nano.2014.06.002","article-title":"Application of heparin as a dual agent with antimalarial and liposome targeting activities toward plasmodium -infected red blood cells","volume":"10","author":"Marques","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0125","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.1021\/nn5054206","article-title":"Nanomimics of host cell membranes block invasion and expose invasive malaria parasites","volume":"8","author":"Najer","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0130","first-page":"1","article-title":"In vitro evaluation of chloroquine - loaded and heparin surface - functionalized solid lipid nanoparticles","author":"Muga","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11095-005-9396-9","article-title":"PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate","volume":"23","author":"Bhadra","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2019.03.031","article-title":"Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria","volume":"562","author":"Ismail","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-016-0179-8","article-title":"Short peptide based nanotubes capable of effective curcumin delivery for treating drug resistant malaria","volume":"14","author":"Alam","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0150","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1021\/cr068407v","article-title":"Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design","volume":"108","author":"Rodriguez","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0155","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1182\/blood.V79.3.798.798","article-title":"Rheological analysis of the adhesive interactions of red blood cells parasitized b plasmodium falciparum rheological analysis of the adhesive interactions of red blood cells parasitized by plasmodium falciparum","volume":"79","author":"Nash","year":"1992","journal-title":"Blood."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.actatropica.2019.04.020","article-title":"Acta Tropica Nano-facilitated drug delivery strategies in the treatment of plasmodium infection","volume":"195","author":"Puttappa","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/1061186X.2017.1291645","article-title":"Malaria treatment using novel nano-based drug delivery systems malaria treatment using novel nano-based drug delivery systems","volume":"25","author":"Baruah","year":"2017","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0170","series-title":"Chapter 16 - Nano Drugs for Curing Malaria: The Plausibility","author":"Gnanadesigan","year":"2019"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0175","doi-asserted-by":"crossref","first-page":"9428","DOI":"10.1039\/D0TB01398F","article-title":"Promising nanomaterials in the fight against malaria","volume":"8","author":"Neves Borgheti-Cardoso","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0180","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1517\/17425247.2016.1167038","article-title":"Novel strategies for Plasmodium-targeted drug delivery","volume":"13","author":"Fern\u00e0ndez-busquets","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0185","first-page":"1095","article-title":"Nanobiotechnological modules as molecular target tracker for the treatment and prevention of malaria: options and opportunity, drug Deliv","volume":"10","author":"Anamika","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41565-021-00866-8","article-title":"Nanotechnology approaches for global infectious diseases","volume":"16","author":"Kirtane","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","article-title":"Targeting the hypnozoite reservoir of plasmodium vivax: the hidden obstacle to malaria elimination","volume":"26","author":"Wells","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro1529","article-title":"The silent path to thousands of merozoites: the plasmodium liver stage","author":"Prud\u00eancio","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020004","article-title":"Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer","author":"Ishino","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0210","article-title":"A plasmodium sporozoite protein with a membrane attack complex domain is required for breaching the liver sinusoidal cell layer prior to hepatocyte infection","author":"Ishino","year":"2005","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2958.2005.05024.x","article-title":"CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts","author":"Kariu","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/j.1462-5822.2008.01143.x","article-title":"The plasmodium TRAP\/MIC2 family member, TRAP-like protein (TLP), is involved in tissue traversal by sporozoites","author":"Moreira","year":"2008","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0225","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M411465200","article-title":"A surface phospholipase is involved in the migration of plasmodium sporozoites through cells","author":"Bhanot","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2017.03.017","article-title":"Cell traversal activity is important for plasmodium falciparum liver infection in humanized mice","author":"Yang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0235","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12817","article-title":"Plasmodium yoelii S4\/CelTOS is important for sporozoite gliding motility and cell traversal","author":"Steel","year":"2018","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.mib.2009.06.006","article-title":"Plasmodium sporozoite-host interactions from the dermis to the hepatocyte","volume":"12","author":"Ejigiri","year":"2009","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpara.2016.09.002","article-title":"Molecular mechanisms of host cell traversal by malaria sporozoites","author":"Yang","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0250","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/9781119436812.ch86","article-title":"The hepatocyte as a household for plasmodium parasites","author":"Zuzarte-Luis","year":"2020","journal-title":"Liver"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0255","article-title":"Malarial cryptozoites","volume":"80","author":"Huff","year":"1943","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0260","doi-asserted-by":"crossref","DOI":"10.1111\/tme.12280","article-title":"Erythrocyte invasion receptors for plasmodium falciparum: new and old","author":"Satchwell","year":"2016","journal-title":"Transfus. Med."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0265","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-019-3575-8","article-title":"Erythrocyte glycophorins as receptors for plasmodium merozoites","author":"Jaskiewicz","year":"2019","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0270","doi-asserted-by":"crossref","DOI":"10.1172\/JCI111907","article-title":"Erythrocyte membrane rigidity induced by glycophorin A-ligand interaction. Evidence for a ligand-induced association between glycophorin a and skeletal proteins","author":"Chasis","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0275","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-04-273904","article-title":"Ligation of complement receptor 1 increases erythrocyte membrane deformability","author":"Glodek","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/nature13715","article-title":"Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies","author":"Wright","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0285","article-title":"Structure and life cycle","author":"Fujioka","year":"2002","journal-title":"Chem. Immunol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/femsre\/fuz005","article-title":"Targeting malaria parasite invasion of red blood cells as an antimalarial strategy","volume":"43","author":"Burns","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0295","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(99)00061-7","article-title":"Tuftsin-bearing liposomes in treatment of macrophage-based infections","volume":"41","author":"Agrawal","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0300","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-291X(87)91118-1","article-title":"Functional drug targeting to erythrocytes in vivo using antibody bearing liposomes as drug vehicles","volume":"148","author":"Agrawal","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0305","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02703366","article-title":"Chloroquine delivery to erythrocytes in plasmodium berghei- infected mice using antibody-bearing liposomes as drug vehicles *","volume":"16","author":"Chandra","year":"1991","journal-title":"J. Biosci."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-6-620","article-title":"Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors","volume":"6","author":"Urb\u00e1n","year":"2011","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0057302","article-title":"Cellular effects of curcumin on plasmodium falciparum include disruption of microtubules","volume":"8","author":"Chakrabarti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0320","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1248\/bpb.b15-00310","article-title":"Evaluation of phosphatidylserine-specific peptide-conjugated liposomes using a model system of malaria-infected erythrocytes","volume":"38","author":"Tagami","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0325","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.2217\/nnm.15.174","article-title":"Polyamidoamine nanoparticles as nanocarriers for the drug delivery to malaria parasite stages in the mosquito vector","volume":"10","author":"Urb\u00e1n","year":"2015","journal-title":"Nanomedicine(Lond.)"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0330","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1021\/cr900157q","article-title":"Dendron-mediated self-assembly, disassembly, and self-organization of complex systems","volume":"109","author":"Rosen","year":"2009","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0335","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1016\/j.biomaterials.2014.04.058","article-title":"Parasite impairment by targeting plasmodium -infected RBCs using glyceryl-dilaurate nanostructured lipid carriers","volume":"35","author":"Jain","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0340","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"59","author":"Date","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0345","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biomaterials.2017.08.020","article-title":"ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model","volume":"145","author":"Moles","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0350","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2016.09.006","article-title":"Development of drug-loaded immunoliposomes for the selective targeting and elimination of rosetting plasmodium falciparum-infected red blood cells","volume":"241","author":"Moles","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2017.03.088","article-title":"Dehydroascorbate-derivatized chitosan particles for targeting antimalarial agents to infected erythrocytes","author":"Shafi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0360","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2011.01.001","article-title":"A nanovector with complete discrimination for targeted delivery to plasmodium falciparum -infected versus non-infected red blood cells in vitro","volume":"151","author":"Urb\u00e1n","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11070341","article-title":"An ImmunoPEGliposome for targeted antimalarial combination therapy at the nanoscale","volume":"11","author":"Biosca","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2015.09.020","article-title":"Artemisinin nanoformulation suitable for intravenous injection: preparation, characterization and antimalarial activities","author":"Ibrahim","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2017.08.016","article-title":"Intravenous human serum albumin (HSA)-bound artemether nanoparticles for treatment of severe malaria","author":"Boateng-Marfo","year":"2018","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2014.01.001","article-title":"Albumin-bound nanoparticles of practically water-insoluble antimalarial lead greatly enhance its efficacy","author":"Ibrahim","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0385","article-title":"Application of heparin as a dual agent with antimalarial and liposome targeting activities towards plasmodium-infected red blood cells","author":"Ms","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0390","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biomac.0c01202","article-title":"Poly(N-vinylpyrrolidone) antimalaria conjugates of membrane-disruptive peptides","author":"Jokonya","year":"2020","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0395","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2013.12.032","article-title":"Use of poly (amidoamine) drug conjugates for the delivery of antimalarials to plasmodium","volume":"177","author":"Urb\u00e1n","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0400","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2478\/afpuc-2019-0009","article-title":"Dual loading of primaquine and chloroquine into liposome","volume":"66","author":"Miatmoko","year":"2019","journal-title":"Eur. Pharam. J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0405","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1166\/jnn.2020.17186","article-title":"Preparation and in vitro \/ vivo evaluation of nano-liposomal form of febrifugine hydrochloride","volume":"20","author":"Wang","year":"2020","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0410","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.addr.2020.09.003","article-title":"When liposomes met antibodies: drug delivery and beyond","volume":"154\u2013155","author":"Di","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0415","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.colsurfb.2017.07.085","article-title":"Immunoliposomes: a review on functionalization strategies and targets for drug delivery","volume":"159","author":"Eloy","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0420","article-title":"CD47 blockade reduces the pathologic features of experimental cerebral malaria and promotes survival of hosts with plasmodium infection","volume":"118","author":"Dulgeroff","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0425","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0000000000000219","article-title":"Red cell receptors as access points for malaria infection","volume":"23","author":"Nichole","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0430","series-title":"Erythrocyte CD55 facilitates the internalization of Plasmodium falciparum parasites","first-page":"1","author":"Bikash","year":"2020"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2014.00299","article-title":"Unraveling the mysteries of serum albumin-more than just a serum protein","author":"Merlot","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0440","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-2-11","article-title":"Uptake of proteins and degradation of human serum albumin by plasmodium falciparum - infected human erythrocytes","author":"Tahir","year":"2003","journal-title":"Malar. J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0445","doi-asserted-by":"crossref","DOI":"10.1159\/000185483","article-title":"A high specificity and affinity interaction with serum albumin stimulates an anion conductance in malaria-infected erythrocytes","author":"Duranton","year":"2008","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0450","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-020-03229-1","article-title":"The malaria parasite plasmodium falciparum in red blood cells selectively takes up serum proteins that affect host pathogenicity","author":"Tougan","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0455","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-020-03438-8","article-title":"Binding of human serum proteins to plasmodium falciparum-infected erythrocytes and its association with malaria clinical presentation","author":"Lopez-Perez","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0460","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V95.2.674","article-title":"Multiple human serum components act as bridging molecules in rosette formation by plasmodium falciparum-infected erythrocytes","author":"Somner","year":"2000","journal-title":"Blood."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0465","series-title":"Handbook of Pharmaceutical Excipients","first-page":"2009","year":"2009"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0470","series-title":"Albumin Nanoparticles\u2014A Versatile and a Safe Platform for Drug Delivery Applications","author":"Zwain","year":"2022"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0475","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/AAC.01238-06","article-title":"Cytotoxic effect of curcumin on malaria parasite plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species","volume":"51","author":"Cui","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0480","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13318-019-00545-z","article-title":"Enhancing curcumin oral bioavailability through nanoformulations","volume":"44","author":"Ipar","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-165","article-title":"Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa","volume":"10","author":"Slavic","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0490","first-page":"C910","article-title":"Human erythrocytes transport dehydroascorbic acid and sugars using the same transporter complex","volume":"306","author":"Sage","year":"2014","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0216457","article-title":"Identification of druggable small molecule antagonists of the plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering","volume":"14","author":"Heitmeier","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01493-8","article-title":"Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria","volume":"20","author":"Tian","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0505","first-page":"1463","article-title":"PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum","volume":"41","author":"Pasternak","year":"2009","journal-title":"Int. J. BioChemiPhysics"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-17","article-title":"Var gene transcription and PfEMP1 expression in the rosetting and cytoadhesive Plasmodium falciparum clone FCR3S1. 2","volume":"10","author":"Albrecht","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0515","series-title":"Heparin: New Life for an Old Drug","author":"Al\u00e1ez-vers\u00f3n","year":"2017"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0520","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1182\/blood-2002-07-2016","article-title":"Heparan sulfate on endothelial cells mediates the binding of plasmodium falciparum \u2013 infected erythrocytes via the DBL1 domain of PfEMP1","volume":"101","author":"Vogt","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0525","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1182\/blood-2009-09-243725","article-title":"Interactions with heparin-like molecules during erythrocyte invasion by plasmodium falciparum merozoites","volume":"115","author":"Boyle","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0530","first-page":"1","article-title":"Exploitation of a newly-identified entry pathway into the malaria parasite-infected erythrocyte to inhibit parasite egress","author":"Glushakova","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12090825","article-title":"Repurposing heparin as antimalarial: evaluation of multiple modifications toward in vivo application","volume":"12","author":"Lantero","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0540","article-title":"Heparin-coated Dendronized Hyperbranched polymers for antimalarial targeted delivery","author":"San Anselmo","year":"2022","journal-title":"ACS Appl. Polym. Mater."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0545","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1016\/S0169-4758(96)10081-8","article-title":"Chondroitin sulphate A as an adherence Receptor for Plasmodium faiciparum infected erythrocytes","volume":"13","author":"Rogerson","year":"1997","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0550","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s40475-020-00213-2","article-title":"Placental malaria","volume":"7","author":"Zakama","year":"2020","journal-title":"Curr. Trop. Med. Reports"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0555","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/bdr2.1496","article-title":"Genesis of placental sequestration in malaria and possible targets for drugs for placental malaria","volume":"111","author":"Clark","year":"2019","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2017.00117","article-title":"Placental malaria: a new insight into the pathophysiology","volume":"4","author":"Sharma","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0565","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-6851(97)00039-X","article-title":"Characterization of macromolecular transport pathways in malaria-infected erythrocytes","volume":"87","author":"Goodyer","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0570","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/BJ20121050","article-title":"Glutathione export from human erythrocytes and plasmodium falciparum malaria parasites","volume":"448","author":"Barrand","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0575","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.colsurfb.2015.09.043","article-title":"Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells","volume":"136","author":"Kesharwani","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0580","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biomaterials.2007.09.024","article-title":"The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0585","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3109\/10837450.2011.653822","article-title":"Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin","volume":"18","author":"Gu","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0590","first-page":"2769","article-title":"Effect of anionic and cationic polyamidoamine (PAMAM) dendrimers on a model lipid membrane","volume":"2016","author":"Lombardo","year":"1858","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-8-183","article-title":"MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of plasmodium falciparum","volume":"8","author":"Bergmann-Leitner","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0600","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2004.03.022","article-title":"Transport of dendrimer nanocarriers through epithelial cells via the transcellular route","volume":"97","author":"Jevprasesphant","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0605","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/0885328207080005","article-title":"Studies on polyamidoamine dendrimers as efficient gene delivery vector","volume":"22","author":"Zhong","year":"2008","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0610","series-title":"Milan Polym. Days Conf.","first-page":"76","article-title":"Amphoteric polyamidoamines as innovative tools to selectively direct antimalarial drugs towards plasmodium-infected red blood cells","author":"Marti","year":"2017"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0615","article-title":"Understanding effects of PAMAM dendrimer size and surface chemistry on serum protein binding with discrete molecular dynamics simulations","volume":"6","author":"Wang","year":"2018","journal-title":"ACS Sustain. Chem. Eng."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0620","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molbiopara.2014.07.006","article-title":"The role of PfEMP1 adhesion domain classification in plasmodium falciparum pathogenesis research","volume":"195","author":"Smith","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0625","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/IAI.73.6.3271-3277.2005","article-title":"Direct activation of human endothelial cells by plasmodium falciparum-infected erythrocytes","volume":"73","author":"Viebig","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0630","doi-asserted-by":"crossref","first-page":"0885","DOI":"10.1371\/journal.pmed.0020245","article-title":"Inhibition of endothelial activation: a new way to treat cerebral malaria?","volume":"2","author":"Wassmer","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0074-02760230033","article-title":"Perillyl alcohol modulates activation, permeability and integrity of human brain endothelial cells induced by plasmodium falciparum","volume":"118","author":"Marin","year":"2023","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0640","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1211\/jpp.61.08.0002","article-title":"Dendrimers as therapeutic agents: a systematic review","volume":"61","author":"Gajbhiye","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0645","first-page":"341","article-title":"Malaria parasite proteins that remodel the host erythrocyte","volume":"7","author":"Maier","year":"2009","journal-title":"Microbiology."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0650","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.2001.81.2.495","article-title":"Membrane transport in the malaria-infected erythrocyte","volume":"81","author":"Kirk","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0655","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.276.5315.1122","article-title":"Membrane network for nutrient import in red cells infected with the malaria parasite","volume":"276","author":"Rathod","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0660","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0166-6851(85)90059-3","article-title":"Charactierzation of permeation pathways appearing in the host membrane of plasmodium falciparum infected red blood cells","volume":"14","author":"Hagai","year":"1985","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000118","article-title":"An erythrocyte vesicle protein exported by the malaria parasite promotes Tubovesicular lipid import from the host cell surface","volume":"4","author":"Tamez","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0670","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/j.1365-2958.2010.07187.x","article-title":"PfCHA is a mitochondrial divalent cation \/ H + antiporter in plasmodium falciparum","volume":"76","author":"Rotmann","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0675","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0014-5793(02)02294-9","article-title":"Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes","volume":"513","author":"Mandal","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0680","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","article-title":"Extracellular vesicles as drug delivery systems: why and how?","volume":"159","author":"Elsharkasy","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0685","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","article-title":"Extracellular vesicles for drug delivery","volume":"106","author":"Vader","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101771","article-title":"Exosome nanovesicles: a potential carrier for therapeutic delivery","volume":"49","author":"Chavda","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2023.08.043_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119627","article-title":"Extracellular vesicles derived from plasmodium-infected and non-infected red blood cells as targeted drug delivery vehicles","volume":"587","author":"Borgheti-Cardoso","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0700","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/9783527827855.ch8","article-title":"Exosomes for drug delivery applications in Cancer and cardiac indications","author":"Pandya","year":"2022","journal-title":"Target Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1009455","article-title":"The ESCRT-III machinery participates in the production of extracellular vesicles and protein export during plasmodium falciparum infection","volume":"17","author":"Avalos-Padilla","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00022","article-title":"Role of extracellular vesicles in cellular cross talk in malaria","volume":"11","author":"Babatunde","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-021-03969-8","article-title":"Extracellular vesicles in malaria: an agglomeration of two decades of research","volume":"20","author":"Opadokun","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2021.811390","article-title":"Antigen discovery in circulating extracellular vesicles from plasmodium vivax patients","volume":"11","author":"Aparici-Herraiz","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0725","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijpara.2021.06.001","article-title":"Proteomic identification of the contents of small extracellular vesicles from in vivo plasmodium yoelii infection","volume":"52","author":"De Sousa","year":"2022","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.jconrel.2023.08.043_bb0730","series-title":"Exosomes from Plasmodium yoelii-Infected Reticulocytes Protect Mice from Lethal Infections","first-page":"1","volume":"6","author":"Martin-jaular","year":"2011"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:48:44Z","timestamp":1759164524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923005436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":145,"alternative-id":["S0168365923005436"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanocarrier based active targeting strategies against erythrocytic stage of malaria","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}